Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 15,643 | 14,634 | 15,393 | 12,503 | 11,363 |
| Cost of Goods | 5,099 | 6,396 | 7,763 | 6,957 | 6,987 |
| Gross Profit | 10,544 | 8,238 | 7,630 | 5,546 | 4,376 |
| Operating Expenses | 13,089 | 14,455 | 15,630 | 16,977 | 18,630 |
| Operating Income | -2,446 | -5,821 | -7,237 | -10,474 | -13,267 |
| Interest Expense | 1,987 | 2,115 | 2,262 | 2,260 | 2,232 |
| Other Income | 670 | 336 | 162 | 39 | 292 |
| Pre-tax Income | -3,763 | -7,600 | -9,337 | -12,695 | -15,207 |
| Net Income Continuous | -3,763 | -7,600 | -9,337 | -12,695 | -15,207 |
| Net Income | $-3,763 | $-7,600 | $-9,337 | $-12,695 | $-15,207 |
| EPS Basic Total Ops | -0.08 | -0.15 | -0.15 | -0.43 | -0.52 |
| EPS Basic Continuous Ops | -0.08 | -0.15 | -0.15 | -0.43 | -0.52 |
| EPS Diluted Total Ops | -0.08 | -0.15 | -0.15 | -0.43 | -0.52 |
| EPS Diluted Continuous Ops | -0.08 | -0.15 | -0.15 | -0.43 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.15 | N/A | N/A | N/A |
| EBITDA(a) | $-1,157 | $-4,313 | $-6,032 | $-9,402 | $-12,256 |